# Strain-specific immune response patterns to Borrelia burgdorferi infection: a comparative transcriptomic analysis in C3H and C57BL/6 mice

**Authors:** Guozhong Zhou, Yan Dong, Huangjuan Zhao, Yu Zhang, Yantong Chen, Meng Liu, Yanshuang Luo, Aihua Liu, Fukai Bao

PMC · DOI: 10.1128/iai.00218-25 · 2026-02-17

## TL;DR

This study compares immune responses in two mouse strains infected with Borrelia burgdorferi to understand why some develop severe arthritis while others do not.

## Contribution

The study identifies strain-specific immune response patterns and their molecular underpinnings in Lyme arthritis development.

## Key findings

- C3H mice showed persistent inflammation with active complement system and inflammasome activity.
- C57BL/6 mice maintained immune stability with fewer differentially expressed genes.
- Transcriptomic analysis revealed 2,183 and 439 differentially expressed genes in C3H and C57BL/6 mice, respectively.

## Abstract

Borrelia burgdorferi (Bb), transmitted through tick vectors, induces Lyme arthritis (LA), with disease progression intimately correlated with host genetic characteristics. Laboratory investigations have demonstrated marked disparities in infection responses among distinct mouse strains: C57BL/6 mice have mild arthritis and rapid tissue repair, whereas C3H mice exhibit severe arthritic manifestations. Comparing these strains has helped identify genetic and immune factors important for arthritis development. In this study, female C57BL/6 and C3H mice were inoculated with Bb via bilateral footpad injection. Disease progression was evaluated through multidimensional parameters, including joint swelling measurements, radiographic examinations, and histopathological analyses at acute (14 days) and chronic (56 days) phases. RNA-seq of joint tissue, combined with single-sample gene set enrichment analysis, immune deconvolution, and multi-omics enrichment revealed strain-divergent signatures. The experimental data unveiled strain-specific immune response patterns: C3H mice exhibited persistent inflammatory responses characterized by heightened complement system activation, sustained inflammatory mediator expression, and prolonged inflammasome activity. C57BL/6 mice maintained relatively stable inflammatory mediator levels and immune homeostasis. Transcriptomic analysis revealed 2,183 (C3H) and 439 (C57BL/6) differentially expressed genes on day 14 post-infection, encompassing processes related to immune cell recruitment, cytokine networks, and complement activation. These findings illuminate the regulatory role of host genetic background in temporal characteristics of immune responses, providing novel molecular insights into differential susceptibility to LA.

## Linked entities

- **Diseases:** arthritis (MONDO:0005578)

## Full-text entities

- **Genes:** Tnfsf10 (tumor necrosis factor (ligand) superfamily, member 10) [NCBI Gene 22035] {aka A330042I21Rik, APO-2L, Ly81, TL2, Tnlg6a, Trail}, C4b (complement C4B (Chido blood group)) [NCBI Gene 12268] {aka C4, Ss}, HLA-A (major histocompatibility complex, class I, A) [NCBI Gene 3105] {aka HLAA}, Cd28 (CD28 antigen) [NCBI Gene 12487], Mcpt1 (mast cell protease 1) [NCBI Gene 17224] {aka Mcp-1}, Il12a (interleukin 12a) [NCBI Gene 16159] {aka IL-12p35, Il-12a, Ll12a, p35}, Cd40 (CD40 antigen) [NCBI Gene 21939] {aka Bp50, GP39, HIGM1, IGM, IMD3, T-BAM}, Cd55b (CD55 molecule, decay accelerating factor for complement B) [NCBI Gene 13137] {aka Daf, Daf-TM, Daf2, TM-DAF}, Cxcl1 (C-X-C motif chemokine ligand 1) [NCBI Gene 14825] {aka Fsp, Gro1, KC, Mgsa, N51, Scyb1}, Cxcl2 (C-X-C motif chemokine ligand 2) [NCBI Gene 20310] {aka CINC-2a, GROb, Gro2, MIP-2, MIP-2a, Mgsa-b}, Tlr2 (toll-like receptor 2) [NCBI Gene 24088] {aka Ly105}, Csf2 (colony stimulating factor 2 (granulocyte-macrophage)) [NCBI Gene 12981] {aka CSF, Csfgm, GMCSF, Gm-CSf, MGI-IGM}, Cd3d (CD3 antigen, delta polypeptide) [NCBI Gene 12500] {aka T3d}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Ctla4 (cytotoxic T-lymphocyte-associated protein 4) [NCBI Gene 12477] {aka Cd152, Ctla-4, Ly-56}, Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 216799] {aka AGTAVPRL, AII/AVP, Cias1, FCAS, FCU, MWS}, B2m (beta-2 microglobulin) [NCBI Gene 12010] {aka Ly-m11, beta2-m, beta2m}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Ccl8 (C-C motif chemokine ligand 8) [NCBI Gene 20307] {aka 1810063B20Rik, HC14, MCP-2, Mcp2, Scya8}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Cd274 (CD274 antigen) [NCBI Gene 60533] {aka A530045L16Rik, B7h1, Pdcd1l1, Pdcd1lg1, Pdl1}, Cd3g (CD3 antigen, gamma polypeptide) [NCBI Gene 12502] {aka Ctg-3, Ctg3, T3g}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Cd4 (CD4 antigen) [NCBI Gene 12504] {aka L3T4, Ly-4}, Il21 (interleukin 21) [NCBI Gene 60505] {aka IL-21}, Itgam (integrin alpha M) [NCBI Gene 16409] {aka CD11b/CD18, CR3, CR3A, Cd11b, F730045J24Rik, Ly-40}, Ccl24 (C-C motif chemokine ligand 24) [NCBI Gene 56221] {aka CKb-6, MPIF-2, Scya24}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, Cxcl16 (C-X-C motif chemokine ligand 16) [NCBI Gene 66102] {aka 0910001K24Rik, CXCL16v1, CXCL16v2, SR-PSOX, Zmynd15, b2b498Clo}, Mefv (Mediterranean fever) [NCBI Gene 54483] {aka FMF, TRIM20, pyrin}, Cd79a (CD79A antigen (immunoglobulin-associated alpha)) [NCBI Gene 12518] {aka Ig-alpha, Iga, Igalpha, Ly-54, Ly54, mb-1}, Masp2 (MBL associated serine protease 2) [NCBI Gene 17175] {aka MASP-2, MAp19}, Cfp (complement factor properdin) [NCBI Gene 18636] {aka BCFG, Pfc}, Tlr12 (toll-like receptor 12) [NCBI Gene 384059] {aka Gm1365, Tlr11}, Ccl5 (C-C motif chemokine ligand 5) [NCBI Gene 20304] {aka MuRantes, RANTES, SISd, Scya5, TCP228}, Csf3 (colony stimulating factor 3 (granulocyte)) [NCBI Gene 12985] {aka Csfg, G-CSF, MGI-IG}, Irak3 (interleukin-1 receptor-associated kinase 3) [NCBI Gene 73914] {aka 4833428C18Rik, IRAK-M}
- **Diseases:** Synovial cell hyperplasia (MESH:D006965), necrotic (MESH:D009336), C3 (MESH:C565169), bacterial infection (MESH:D001424), autoimmune thyroid disease (MESH:D013967), type I diabetes (MESH:D003922), infection (MESH:D007239), bone erosions (MESH:D014077), articular (MESH:D057072), type IIa hypersensitivity (MESH:D006938), joint swelling (MESH:D007592), Arthritis (MESH:D001168), restricted mobility (MESH:D014086), viral myocarditis (MESH:D014777), bacterial colonization (MESH:D015179), thyroiditis (MESH:D013966), arthritic (MESH:D015535), autoimmune disease (MESH:D001327), Ankle joint swelling (MESH:D016512), Fibroplasia (MESH:D012178), carditis (MESH:D009205), edema (MESH:D004487), Bb infection (MESH:D008193), articular damage (MESH:D012213), graft-versus-host disease (MESH:D006086), Inflammatory (MESH:D007249)
- **Chemicals:** DAB (MESH:C000469), Formalin (MESH:D005557), CO2 (MESH:D002245), citrate (MESH:D019343), H&amp;E (MESH:D006371), Barbour-Stoenner-Kelley II medium (-), hematoxylin (MESH:D006416), water (MESH:D014867), paraffin (MESH:D010232)
- **Species:** Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Borreliella burgdorferi (Lyme disease spirochete, species) [taxon 139]
- **Cell lines:** C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), /6 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_5985), R-MMU-6798695 — Homo sapiens (Human), Transformed cell line (CVCL_E780), C3H — Mus musculus (Mouse), Finite cell line (CVCL_HA23)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12974124/full.md

---
Source: https://tomesphere.com/paper/PMC12974124